• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,164
2,283
1,859
1,828
1,712

COUNTRY

877
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,127
    • 99
  • 385
  • 271
  • 251
  • 65
  • 379
  • 673
  • 1,258
  • 1,621
  • 625
  • 883
  • 1,673
  • 2,638
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 727
  • 0
  • 97

PRICE

6,739
11,286
16,980
24,682

PUBLISHED

1,615
3,018
7,011
24,682

PRODUCT TYPE

20,309
3,174
856
164
74
44
21
21
12
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2013

Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2013', provides an...

June 2013
FROM

Pseudomonas Infections - Pipeline Review, H1 2013

Pseudomonas Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pseudomonas Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

June 2013
FROM

Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2013

Dry (Atrophic) Macular Degeneration – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2013', provides an overview of the indication’s...

June 2013
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain Summary GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and...

June 2013
FROM

Dementia - Pipeline Review, H1 2013

Dementia – Pipeline Review, H1 2013 Summary 'Dementia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development...

June 2013
FROM

Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2013

'Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development...

June 2013
FROM

Seasonal Allergic Rhinitis - Pipeline Review, H1 2013

'Seasonal Allergic Rhinitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Seasonal Allergic...

June 2013
FROM

Addiction - Pipeline Review, H1 2013

Addiction – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Addiction - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

June 2013
FROM

Leukemias - Pipeline Review, H1 2013

'Leukemias - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Leukemias, complete with latest...

June 2013
FROM

Thyroid Cancer - Pipeline Review, H1 2013

Thyroid Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Thyroid Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

June 2013
FROM

Bacterial Infections - Pipeline Review, H1 2013

Bacterial Infections – Pipeline Review, H1 2013 Summary 'Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information...

June 2013
FROM

Muscular Dystrophy - Pipeline Review, H1 2013

Muscular Dystrophy – Pipeline Review, H1 2013 Summary 'Muscular Dystrophy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information...

June 2013
FROM

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2013

'Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for...

June 2013
FROM

Recurrent Malignant Glioma - Pipeline Review, H1 2013

'Recurrent Malignant Glioma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Recurrent Malignant...

June 2013
FROM

Neurology - Pipeline Review, H1 2013

'Neurology - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Neurology, complete with latest...

June 2013
FROM

Brain Injury - Pipeline Review, H1 2013

Brain Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Brain Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

June 2013
FROM

Gram-Negative Bacterial Infections - Pipeline Review, H1 2013

'Gram-Negative Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Gram-Negative...

June 2013
FROM

Insulin Resistance - Pipeline Review, H1 2013

'Insulin Resistance - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Insulin Resistance,...

June 2013
FROM

Hematological Tumor - Pipeline Review, H1 2013

Hematological Tumor – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hematological Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

June 2013
FROM

PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022 Summary Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection...

June 2013
FROM
Loading Indicator

Our Clients

Our clients' logos